Expression of CD99 in Multiple Myeloma: A Clinicopathologic and Immunohistochemical Study of 170 Cases

BACKGROUND: Multiple myeloma (MM) is a heterogeneous and ultimately fatal disease. Risk stratification using prognostic biomarkers is crucial to individualize treatments. We sought to investigate the role of CD99, a transmembrane protein highly expressed in many hematopoietic cells including subpopu...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Su-Jin, Lee, Hyangsin, Jung, Geunyoung, Gil, Minchan, Park, Hosub, Park, Young Soo, Yoon, Dok Hyun, Suh, Cheolwon, Park, Chan-Jeoung, Huh, Jooryung, Park, Chan-Sik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Society of Pathologists and The Korean Society for Cytopathology 2014
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087134/
https://www.ncbi.nlm.nih.gov/pubmed/25013419
http://dx.doi.org/10.4132/KoreanJPathol.2014.48.3.209

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4087134/
https://www.ncbi.nlm.nih.gov/pubmed/25013419
http://dx.doi.org/10.4132/KoreanJPathol.2014.48.3.209

Ejemplares similares